Mucositis

The grounding supports chemical irritation, chemotherapy, and radiotherapy as causes of mucositis. Oral mucositis is described as a complication of cancer therapy, and the literature specifically discusses radiotherapy and chemotherapy as triggers. No other causes are supported by the supplied material.

The disease involves inflammatory injury to mucosa with atrophy of the squamous epithelium, vascular damage, inflammatory cell infiltration, and ulceration. In oral mucositis, inflammation is a central feature of the destructive and ultimately ulcerative process. The innate immune response, including barrier function, pattern-recognition systems, and microbial composition, is highlighted as an important contributor to early damage signaling.

The supplied grounding does not provide general patient-level risk factors for mucositis. It does indicate exposure to chemotherapy, radiotherapy, and chemical irritation as settings in which mucositis occurs. No additional risk factors are supported.

The grounding supports drug therapy as the relevant management modality, but it does not specify particular drug classes for mucositis itself. The review abstract notes that management strategies for oral mucositis are limited. For peri-implant mucositis, the guideline emphasizes prevention and treatment within interdisciplinary dental implant care, but no specific therapeutic class is provided for mucositis generally.